Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Blood
; 139(6): 942-946, 2022 02 10.
Article
in English
| MEDLINE | ID: covidwho-1571738
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
ADP-ribosyl Cyclase 1
/
Antineoplastic Agents, Immunological
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
/
Multiple Myeloma
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
/
Variants
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Blood
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS